dismiss

Clean Sweep Live Auction on Wed. May 1st. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Rad Oncology Homepage

Fivefold difference found in Medicaid reimbursements for radiotherapy May limit access to healthcare, especially in rural areas

Trends in radiation oncology workforce potentially threaten rural patients, says study More radiation oncologists leaving, fewer coming in to rural areas

Varian showcases first preclinical findings of Flash therapy trial Reductions in radiation lung fibrosis and dermatitis

Female oncologists submit fewer charges, paid less than male Study bases findings on Medicare records

Four considerations before embarking on a carbon therapy center The next frontier in improving cancer care

New approach identifies lung cancer patients most likely to respond to chemotherapy Combines radiomics and CT image assessment

Q&A with Scott Warwick, executive director of the National Association for Proton Therapy Find out what to expect at the year's biggest proton therapy industry event

Aussies and Americans develop 3D models for assessing impacts of radiotherapy Test different levels and types of radiation

Law in Ontario prevents cremation of brachytherapy patients Experts call for eliminating the law, as it deters patients from lifesaving treatment

IBA tech plays first-time role in flash therapy demonstration Supports eventual integration of flash as clinical treatment

Could this mean lights-out
for cancer?

Mayo Clinic researchers discover molecular 'code' for 'turning off' cancer cells

by John W. Mitchell , Senior Correspondent
Just as you would flip a switch to turn off a light, a new discovery by Mayo Clinic scientists may point the way to shutting off the growth of cancer cells.

“We found that an adhesion protein, the glue that keeps normal cells together, suppresses cell growth through small molecules called miRNAs,” Dr. Antonis Kourtidis told HCB News. “We discovered that this structure is missing in many tumors.”

Story Continues Below Advertisement

New & Refurbished C-Arm Systems. Call 702.384.0085 Today!

KenQuest provides all major brands of surgical c-arms (new and refurbished) and carries a large inventory for purchase or rent. With over 20 years in the medical equipment business we can help you fulfill your equipment needs



In cultured cell experiments, loss of miRNAs results in abnormal cell growth. But when the miRNAs are restored, abnormal growth was significantly suppressed, according to Kourtidis.

Kourtidis and the other researchers think the discovery of this new, unexpected biology “provides the code, the software for turning off cancer," adding that preliminary results in aggressive breast and bladder cancer cultured cells have been encouraging.

Obviously, the practical use of these findings will take some time.

“There are still many more steps and several years down the road for an actual treatment to be developed from this discovery,” said Kourtidis. “Extensive research needs to be done in identifying the affected miRNAs in each tumor type, in preclinical models, in miRNA delivery methods and, of course, in clinical trials.”

The miRNAs orchestrate whole cellular programs by simultaneously regulating expression of a group of genes. The investigators found that when normal cells come in contact with each other, a specific subset of miRNAs suppresses genes that promote cell growth. However, when adhesion is disrupted in cancer cells, these miRNAs are misregulated and cells grow out of control.

The nuts and bolts of the study are significant, as it brings together two so far unrelated research fields – cell-to-cell adhesion and miRNA biology.

Kourtidis noted that the role of adhesion proteins in cell behavior has long baffled scientists. But now that this link has been discovered, it uncovers a new strategy for cancer therapy.

“Our findings provide a roadmap for a new approach to treatment based on these very small molecules called miRNAs,” he stressed. “However, again, it is still very early to predict how successful this will be. It is very likely this therapy would be combined with current treatments. And of course surgery may also still be necessary.”

The result of their research was published in Nature Cell Biology.

Rad Oncology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED